The rising trend in levels of advanced care for women in labour has prompted the recommendation for the development of safe and effective alternatives to regional analgesia. The most powerful influence on a woman's satisfaction with pain relief appears to be the attitude and behaviour of her caregiver. Despite the continued lack of any high-powered randomised controlled trials, there are a number of simple and safe nonpharmacological options available for pain relief. Evidence suggests that intramuscular diamorphine is a better analgesic than intramuscular pethidine. Remifentanil patient-controlled analgesia has emerged as an alternative to regional anaesthesia but there are concerns with its safety. Epidural analgesia remains the most effective form of pain relief for labour.
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Learning objectives
To provide an overview of the different types of analgesia available for labour. To understand the mechanism of action, dosages and adverse effect profiles of pharmacological analgesics. To discuss regional analgesia and their indications and contraindications.
Introduction
Childbirth is a normal life event yet it is considered one of the most painful experiences of a woman's life. A woman's ability to cope with labour pain appears to be influenced by her parity, complex psychosocial factors such as fear and anxiety, prior experience of labour, culture, ethnicity, emotional support, antenatal class attendance and educational attainment. 1 Pain originates from different sites during labour and childbirth. In the first stage of labour, pain is transmitted via the spinal nerves of T10-L1 and results from uterine contractions and dilatation of the cervix. In the second stage, stretching of the pelvic ligaments causes pain via the pudendal nerve originating from the S2-S4 nerve roots. 2 There has been a rising trend in the levels of advanced care for women in labour, primarily due to an increase in births occurring in non-UK nationals, an increased incidence of comorbidities such as obesity, and greater maternal expectations. This has prompted a number of recommendations for analgesia in labour, 3 as well as the development of evidence-based guidelines for analgesia in labour, the most recent of which is the National Institute for Health and Care Excellence guidance on intrapartum care. 4 These are all particularly important since it is reported that healthcare professionals often underestimate the intensity of pain experienced by women in labour and overestimate the relief offered by the analgesia provided during labour. 5 Pain management strategies for women in labour include non-pharmacological, pharmacological and regional analgesia. This article aims to provide the obstetrician with an overview of analgesic options in labour with reference to current evidence. are intended to reduce the medicalisation of labour and reduce the loss of control often experienced following pharmacological or regional analgesia. 6 They are generally inexpensive, easy to institute and low risk; however, there is only poor-quality evidence supporting their effectiveness in reducing moderate to severe labour pain.
Continuous one-to-one support and the care provider Evidence suggests that pain perception is strongly influenced by the attitude and behaviour of the woman's caregiver, which is probably the single most important factor in a woman's perception of pain during labour and childbirth. 4 A designated midwife during labour is associated with a lower analgesic requirement, reduced instrumental delivery and lower rates of dissatisfaction with childbirth. 7 Women in labour can also self-fund a companion (or 'doula') to provide non-medical care.
Prenatal information
Providing women with prenatal information about the labour experience including analgesic options has been shown to reduce pain levels during labour. 8 All care providers are expected to provide appropriate resources to women through documented information or the availability of specialists such as obstetric anaesthetists. The Obstetric Anaesthetists' Association has produced a number of information resources about pain relief and related topics for patients and their carers in a web portal (LabourPains.com). The resources are free of charge and available in a number of languages. 9 The National Childbirth Trust runs classes and seminars nationally that provide information and practical sessions for women on topics including pain relief during labour.
Music
It has been proposed that music reduces anxiety levels and catecholamine production and provides 'distraction' to pain during labour. 10 A meta-analysis of 22 studies in a broad range of populations showed that music and music-assisted relaxation techniques significantly reduce arousal due to stress. 11 Many maternity units in the UK offer facilities such as iPod docking stations so that women can easily listen to their preferred choice of music during labour.
Aromatherapy
Aromatherapy is the application of essential oils to the skin or inhalation of the scents of essential oils and their use in labour is increasing in popularity. 12 It is postulated that essential oils can increase the production of the body's sedative, stimulant and relaxing neurotransmitters. Level 3 evidence suggests that aromatherapy also improves psychological wellbeing for hospital inpatients. 13 A meta-analysis of two trials (n=535) found that aromatherapy provided no benefit in reduction of labour pain.
14 However, a 2014 randomised controlled trial (RCT) (n=160) demonstrated a reduction in pain intensity in those using lavender aromatherapy with no adverse maternal or fetal effects, and no impact on the duration of labour or Apgar scores. 15 
Acupuncture and acupressure
Acupuncture and acupressure involves the insertion of fine needles or application of pressure to specific areas of the body. It is widely believed that these techniques work through the stimulation of touch fibres, which block pain impulses at the 'pain gates' within the spinal cord and the modification of endorphin release, which alters pain perception. 2 A major limitation of the evidence available for the use of acupuncture in labour is the high risk of bias due to an inability to blind participants and evaluators. A systematic review of ten RCTs (n=2038) showed that acupuncture was not superior to sham acupuncture (where acupuncture needles are inserted into non-acupuncture points) in reducing labour pain at 1 hour or at 2 hours. Acupuncture did, however, reduce pain by 11% compared with placebo for the first 30 minutes of labour. 16 Despite the limited and mainly level 4 evidence, many national maternity units still provide an acupuncture service.
Birthing balls and posture
A birthing ball is an air-filled rubber ball (approximately 60 cm in diameter), which a woman can sit on during labour, assisting her to adopt an upright position, and allowing a rocking movement during labour. One RCT (n=188) demonstrated a 30-40% reduction in labour pain following the implementation of a birthing ball exercise programme in labour. Women in the birthing ball group also had a shorter first stage of labour, less epidural requirement and fewer caesarean sections. 17 There is, however, limited evidence on the use of birthing balls to prevent severe labour pain and some institutions in the UK have not supported their use because of safety concerns.
A Cochrane systematic review 18 (n=5218) also supported adopting an upright position during labour, showing a reduction in analgesic requirements, a shorter first stage of labour of 1 hour 20 minutes and a reduction in the rate of caesarean sections. Additionally, upright positions also appear to shorten the second stage of labour, reduce instrumental delivery rates and episiotomies, but increase blood loss. 19 
Transcutaneous electrical nerve stimulation
Transcutaneous electrical nerve stimulation (TENS) is the application of low-voltage electrical impulses to the lower back. In labour, it is most often applied at the vertebral levels T10 to S2, where nerve pathways from the uterus, vagina and perineum enter the spinal cord. It is a popular nonpharmacological form of analgesia because it has the potential to allow women in labour to control their pain relief through changing the frequency and intensity of the electrical impulses delivered. The mechanism of action is poorly understood but electrical pulses are believed to block the transmission of pain impulses within the spinal cord. A secondary benefit is thought to be the release of endorphins, which mediate pain perception. 5 A Cochrane review of 17 studies (n=1466) 20 demonstrated that women using TENS had similar pain scores to a control group. In four studies where TENS machines were compared with inactive placebo machines, 63% of women in the TENS group reported they would use TENS in future labours, however, 41% of the placebo group also reported wanting to use the placebo again. This perhaps suggests the device itself and an element of control may be more of a benefit than the physiological impact of the intervention. 20 The analgesic effect of TENS in the latent phase of labour remains unclear. 4 
Sterile water injections
Based on the 'gate control' theory, sterile water injected subcutaneously or intracutaneously into the area of the lumbosacral spine is believed to inhibit the transmission of pain by stimulating large afferent nerve fibres. 21 Four to six injections of water (0.1 ml) can be administered over the painful area and the therapy can be repeated with minimal adverse effects. 22 Several systematic reviews of RCTs have indicated that this therapy can significantly reduce pain in labour. 23 Pain scores are reduced by as much as 60% and can last for up to 2 hours. 4 One study found that those receiving sterile water injections experienced less labour pain than those using acupuncture. 22 This practice has not, however, been routinely adopted in the UK.
Water immersion
Warm water immersion has a long history of use in labour, being used during any stage of labour and for any duration of time. The proposed mechanism of pain relief is a physiological increase in uterine perfusion, which may promote endorphin and oxytocin release, thus increasing maternal satisfaction.
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A meta-analysis of 12 trials (n=3243) demonstrated that women using water immersion experienced less pain than those not labouring in water. 24 There was also a reduction in duration of the first stage of labour and those randomised to labour in water also required less subsequent neuraxial analgesia than women in the control group. There was no difference in assisted vaginal delivery, caesarean section, the use of oxytocin, perineal trauma or maternal infection.
The temperature of the pool should be checked hourly to ensure the woman is comfortable and not becoming pyrexial. The water temperature should also not exceed 37.5°C. 4 There is a lack of evidence on the timing of water use in labour and on hygiene measures for water birth. 4 
Hypnosis
During labour, hypnosis (or 'hypnobirthing') can be used to focus attention on calm and comforting influences, increase a woman's receptivity to positive 'suggestions' and reduce the awareness of external stimuli. It may help to relieve pain but also to enhance feelings of relaxation, safety and control. 25 It is proposed that hypnosis affects the anterior cingulate gyrus of the limbic system and can suppress the neural activity between the sensory cortex and the amygdala-limbic system. 2 Hypnosis can be delivered by a practitioner-led method or by self-hypnosis with audio instruction. It should be noted that when a woman is hypnobirthing, she is more susceptible to suggestion and therefore staff involved in her care should be made aware and endeavour to use positive or hypnobirthing terminology where possible (Table 1) .
Meta-analyses disagree over the effectiveness of hypnosis; one meta-analysis involving five RCTs showed that hypnosis was associated with a reduction in the use of pharmacological pain relief and the need for labour augmentation, 4 while another (seven RCTs, n=1213) reported no difference in pain scores or maternal satisfaction between hypnosis and control groups. 25 
Biofeedback
Biofeedback is a form of behavioural therapy aimed at training women in labour to recognise various body signals such as changes in heart rate, muscle tension or temperature and to change their body responses with the aid of electronic instruments. A review of four studies (n=186) assessing mainly electromyographic biofeedback for muscle tension failed to reach a conclusion on whether this form of therapy was effective in labour. Nitrous oxide (gas and air)
Gas and air (Entonox â ) is a mixture of inhaled nitrous oxide plus oxygen in a fixed 1:1 ratio. It has been available since 1962 and approved for administration by midwives since 1970. It is the most popular form of analgesia for mild labour pain and should be available to all labouring women in the UK. 4 It acts as a very weak anaesthetic at high concentrations and as an analgesic and anxiolytic at lower concentrations. 5 It suppresses activity within the reticulo-endothelial system and increases the release of endogenous endorphins, corticotrophins and dopamine, which activate descending pain pathways. 28 Nitrous oxide has a short half-life of 2-3 minutes and is cleared rapidly via the lungs.
Nitrous oxide probably does not interfere with endogenous oxytocin and is unlikely to affect the labour process or spontaneous vaginal birth rate. While it crosses the placenta readily, nitrous oxide does not affect the fetal heart rate or respiratory rate in the newborn. 29 Common adverse effects include lightheadedness, nausea, vomiting and, less commonly, hallucinations, hyperventilation and tetany. Prolonged nitrous oxide exposure for more than 5 hours per week in some healthcare workers has been linked to decreased fertility, preterm birth and vitamin B12 deficiency, although such side effects have not been reported with its use in labour. 5, 30 In trials comparing nitrous oxide with a placebo, pain scores are lower in women in the nitrous oxide group. However, the incidence of nausea, vomiting, dizziness and drowsiness is higher than in women in the placebo group. 2 Despite nitrous oxide being one of the popular analgesic options in the UK, a large systematic review of 58 studies, carried out in 2014, found few good-quality studies supporting the use of nitrous oxide for labour pain. 31 
Non-opioid analgesics
Non-opioids include paracetamol, non-steroidal antiinflammatory drugs, sedatives and antispasmodics. Other than paracetamol, these drugs are seldom used in the UK and will not be discussed further here.
Paracetamol is a cyclo-oxygenase 2 inhibitor that reduces the inflammatory response and subsequent pain by blocking the production of prostaglandins via the arachidonic acid pathway. Adverse effects are rare and it appears that when used in therapeutic doses, paracetamol is not toxic to the fetus. Paracetamol hepatotoxicity is, however, one of the top causes of acute fulminant liver failure in young individuals worldwide and is a potential maternal concern. Paracetamol offers better pain relief and satisfaction with the childbirth experience than placebo. 32 
Opioids
Commonly used opioids include dihydrocodeine, pethidine, diamorphine, fentanyl and remifentanil. Intramuscular pethidine is the most commonly used opioid worldwide for labour analgesia and is one of the most frequently used in the UK because midwives are licensed to prescribe and administer it. 33 Tramadol, meptazinol and pentazocine are not used routinely in the UK although evidence suggests no advantage over pethidine. 4 Opioid receptors are mainly located in the periaqueductal grey area of the brain and spinal cord, with sparse locations elsewhere. Their activation leads to a reduction in neuronal cell excitability and transmission of nociceptive impulses. 34 Adverse effects of all opioids include drowsiness, hypoventilation, urine retention, nausea/vomiting and an increase in gastrointestinal transit time (with a risk of aspiration). Opioids cross the placenta by passive diffusion and some are trapped by ionisation. 35 Opioids will often produce a prolonged 'sleep phase' pattern on cardiotocography, with a reduction in fetal heart rate variability, accelerations and decelerations. A neonate may take up to 6 days to eliminate pethidine from its system, with respiratory depression, hypothermia, poor feeding, altered crying and decreased alertness as recognised adverse effects. 35 A large systematic review of 57 studies (n=7000) assessing the use of opioids in labour found that parenteral opioids provide some effectiveness in relief from pain in labour but are associated with a number of adverse maternal and fetal effects. 36 Maternal satisfaction with any specific opioid analgesia was largely unreported but appeared moderate at best. There is also evidence that other pharmacological interventions such as nitrous oxide appear to have a better analgesic effect than opioids for labour pain. 37 
Intramuscular pethidine versus diamorphine
In 2014 a two-centre double-blind RCT of 406 women (the IDvIP trial) 38 compared the analgesic efficacy and adverse effect profile of two of the most commonly used opioid analgesics in the UK: intramuscular pethidine and intramuscular diamorphine. Results of the study showed that intramuscular 7.5 mg diamorphine gave significantly better analgesia than 150 mg pethidine but prolonged delivery by approximately 82 minutes. Women given diamorphine were also more likely to be satisfied with their analgesia. There were no significant differences in neonatal adverse outcomes between the two medications. It is worth noting, however, that the authors of the study do not recommend the use of intramuscular diamorphine in labour because of the prolonged delivery time and the cost.
Patient-controlled analgesia
Patient-controlled analgesia (PCA) is the delivery of drugs through a preprogrammed pump. The programming usually involves clinician input plus self-administered boluses by the patient. It offers an alternative to regional analgesia where regional anaesthesia is unavailable, unsuccessful, contraindicated or refused. Although a number of opioids have been reported for their use in PCA, the only one widely used in the UK for labour pain is remifentanil.
Remifentanil PCA
Remifentanil is a rapidly acting synthetic opioid, which is rapidly metabolised by tissue esterases and has a half-life of 3 minutes. 39 One-third of labour units in the UK now offer remifentanil PCA as a form of analgesia. 40 Table 2 gives a summary of the indications, benefits and adverse effects of epidurals versus remifentanil PCA.
Widespread national and international implementation has been hampered by concerns over its safety. Respiratory depression is reported in up to 32% of patients and 5% encounter oxygen saturations below 90%. 41 Eleven percent of respondents in a UK survey reported critical incidences relating to the use of remifentanil and respiratory depression. 40 Alarmingly, there have been a number of reported cases of respiratory and cardiac arrest associated with the use of remifentanil PCA. 42, 43 Continuous oxygen saturation monitoring is therefore mandatory during its use. Other common adverse effects of remifentanil include maternal pruritus, nausea and vomiting.
Another issue with remifentanil PCA is the potential tolerance that may occur after just 60 minutes of use, resulting in a reduction in efficacy. 44 There are also concerns regarding the pharmacokinetic profile of remifentanil. A bolus dose of the drug has a peak effect 1-3 minutes after administration, which often results in suboptimal analgesia for contraction pain because it is used either too early or late. Likewise, its effect on respiration is also delayed by some 2-4 minutes from administration meaning respiratory depression is sometimes missed. 45 A variety of dosing regimens exist but generally tend to involve a bolus dose of remifentanil of 0.15-1 micrograms/kg with a 2-minute lock out and a background infusion of 0.025-0.05 micrograms/kg/minute. There are however wide variations according to local policies. 46 A 2013 observational study suggests a stepwise approach to the use of remifentanil to avoid initial overdosing. 47 The study recommended a bolus dose range of 0.15-1.05 micrograms/kg which was found to provide analgesia with high maternal satisfaction and low maternal and fetal adverse effects. The authors advocated increasing the bolus dose by steps of 0.15 micrograms/kg, a dose calculation (based on lean body mass) with a lock out time of 2 minutes. A maximum bolus dose of no greater then 0.7 micrograms/kg remifentanil is also recommended.
A comprehensive list of relative contraindications to remifentanil PCA is yet to be established but could include morbid obesity, clinical features of a chest infection and primigravida women who are at risk of prolonged labour. 48 Remifentanil has been compared with other analgesics in labour, with the main question being whether it provides equivocal analgesia to epidural analgesia. A meta-analysis of five studies comparing epidural analgesia with remifentanil PCA found it was not superior to epidural analgesia in analgesic efficacy during labour. 49 The study found wide confidence intervals in the pooled results for secondary maternal and neonatal outcomes meaning definite conclusions could not be drawn for those outcomes. 49 There are also still many unanswered questions and a lack of national guidance regarding the use of remifentanil, including the optimal regimen, the importance of trained midwifery staff and whether there is the need for apnoea monitoring and or capnography during its use. 48 
Regional analgesia
Regional analgesia remains the gold standard for pain relief in labour, with more than 150 000 women opting for epidural analgesia for pain relief in labour annually in the UK. 37 Regional analgesia was first introduced in the 1960s and includes epidural, combined spinal-epidural and spinal analgesia. No woman should be refused regional analgesia on the basis of her original birth plan, stage of labour (unless delivery is imminent) and/or relative/spouse request. 4 The indications and contraindications for regional analgesia are outlined in Table 3 .
Epidural anaesthesia
Epidural anaesthesia involves the use of local anaesthetics with or without an opioid injected into the epidural space to produce a reversible loss of sensation and motor function. Local anaesthetics inhibit nerve conduction by blocking sodium channels in nerve cell membranes, thereby preventing the propagation of nerve impulses. Since the 1980s, the advent of lower concentration of local anaesthetic solutions in combination with a variety of opiates (such as 0.0625-0.1% bupivacaine and 2 micrograms/ml fentanyl) has vastly reduced the adverse effects of epidural anaesthesia in labour and has improved maternal satisfaction. Improvements include the retention of more motor function and even the ability to walk during labour (known as a 'mobile epidural'), better ability to bear down and also a reduction in hypotension and its accompanied adverse effects. The use of the PCEA allows the woman to be in control of her pain by self-administered top-ups. PCEA pumps are preprogrammed with a set dose and lock out time (usually 30 minutes) to avoid high blocks and toxicity. In contrast to other maintenance regimens, the use of PCEA is associated with lower pain scores, less motor block and better maternal satisfaction. 4 The exact regimen used is dependent on local policy. The care and observations for insertion and maintenance of regional analgesia are shown in Box 1.
Women should be provided with information regarding the benefits and drawbacks of regional analgesia prior to labour; the Obstetric Anaesthetists' Association provides a summary of these. 50 The National Audit Project 3, one of the largest studies conducted on regional analgesia, highlighted the safety of epidural analgesia in labour, finding an incidence of 1:54 000 of permanent injury and a 1:140 000 risk of paraplegia or death. 51 There is high-level evidence that epidural analgesia is associated with a prolonged second stage of labour and increased instrumental delivery rates. 2, 52 There is, however, no association with a prolonged first stage of labour, increased risk of caesarean section or long-term back problems, which epidurals have been commonly associated with. 2, 4 Epidural analgesia during labour is associated with an improved neonatal acid-base status, suggesting that placental exchange is well maintained during epidural analgesia. 4 See Table 2 for a summary of the indications, benefits and adverse effects of epidurals.
Combined spinal and epidural
Epidural analgesia during labour can also be provided in the form of a combined spinal-epidural (CSE). This involves a single injection of local anaesthetic and/or opioid into the subarachnoid space (spinal) and the insertion of an epidural catheter with the use of the epidural as per usual once the effects of the spinal analgesia wear off. The main advantage of the CSE is the rapid onset of pain relief it provides compared with conventional epidural and it can be useful in women with very severe labour pain. It has been postulated that the hole in the dura from a CSE results in spread of epidural local anaesthetic into the subarachnoid space as well as the epidural space, increasing the effectiveness of analgesia. This, however, is unclear with evidence suggesting that epidural anaesthesia and CSE have the same analgesic effect over the duration of the labour. 4 A meta-analysis comparing both showed maternal satisfaction, caesarean delivery rates and mobility as being similar but with adverse effects such as pruritus more common with CSEs. There were also no differences in umbilical pH, Apgar score or neonatal outcomes. 53, 54 A disadvantage of CSE is the uncertainty over whether the epidural is working immediately because of the initial effects of the spinal injection. In a number of institutions, CSE has replaced epidural anaesthesia as the primary form of regional analgesia offered to labouring women.
Practical issues with regional analgesia
Time from epidural request to the anaesthetist attending Until the advent of a 24-hour consultant-delivered anaesthesia service, labour ward units in the UK continue to face an ever-increasing obstetric population often manned only by a single anaesthetist during unsociable hours. The Royal College of Anaesthetists recommends that time from epidural request to the anaesthetist attending should not exceed 30 minutes, after which a second anaesthetist should be available. 55 
Obese patients
Obesity is associated with increased maternal and fetal morbidity and mortality, including increased rates of labour dystocia, fetal distress, operative delivery, postpartum haemorrhage and anaesthesia-related complications. 55, 56 Many authorities, such as the American Congress of Obstetricians and Gynecologists, recommend the insertion of an early epidural anaesthesia in obese mothers to alleviate or prevent these issues. 56 Despite this recommendation, the technicalities of epidural insertion in the obese woman include multiple attempts at insertion, longer epidural needles and higher rates of dural puncture and epidural migration into the fatty subcutaneous tissue. 57 Ultrasound guidance to facilitate catheterisation of the epidural space may help overcome such difficulties. Both real-time ultrasound and pre-puncture ultrasound improve the success rate of catheter insertion. In an RCT comparing real-time ultrasound, prepuncture ultrasound and no ultrasound in pregnant women (n=30), only one puncture attempt was required in 100% (10/10), 70% (7/10) and 40% (4/10), respectively. 58 Box 1. Care and observations recommended for regional analgesia 4 Intravenous access prior to commencing regional analgesia Do not administer routine preloading and maintenance fluid Check blood pressure every 5 minutes for 15 minutes during establishment or after further boluses Anaesthetic review after 30 minutes if woman not pain-free Check sensory block hourly Continuous electronic fetal monitoring for 30 minutes during establishment or after boluses of 10 ml or more ª 2015 Royal College of Obstetricians and Gynaecologists
Maternal request for epidural near or at full dilatation
The American Congress of Obstetricians and Gynecologists recommends that 'maternal request is a sufficient indication for analgesia during labour'. 59 However, where vaginal delivery is imminent, the decision to offer regional anaesthesia should be individualised to avoid the potential risks of regional anaesthesia. This decision will depend on various factors including a woman's parity, the fetal condition on cardiotocograph and whether a prolonged or difficult second stage is anticipated, such as malposition of the fetus and macrosomia.
Conclusion
Analgesia in labour plays a crucial part in affecting maternal satisfaction during one of the most painful periods of a woman's life. This article has discussed the main analgesic options that exist for labouring women in the UK - Table 4 provides an overview of the evidence for the analgesic options discussed. Also key to providing the best possible analgesia for the labouring woman is the provision of appropriate and relevant information on labour analgesics and continuous oneto-one support from a trained individual provider during labour. While a number of pharmacological and nonpharmacological options exist for labour pain, epidural anaesthesia remains the gold standard for severe pain. Over the last decade, the biggest changes in labour analgesia in the UK have been the spectrum of non-pharmacological treatments available and the advent of remifentanil PCA. Continuing safety concerns and issues with clinical effectiveness with prolonged use have, however, limited the widespread adoption of remifentanil PCA.
Disclosure of interests
The authors declare no conflicts of interest.
Contribution to authorship
DIA: conception and design, acquisition of data and analysis/ interpretation of data, drafting the article, final approval of the version to be published. YK: acquisition of data, drafting the article, final approval of the version to be published. CK: acquisition of data, drafting the article, final approval of the version to be published. AM: revising the article critically for important intellectual content, final approval of the version to be published. SF: revising the article critically for important intellectual content, final approval of the version to be published. RK: drafting the article, revising the article critically for important intellectual content, final approval of the version to be published.
